Volitionrx (VNRX) Revenue Growth (1y) (2020 - 2025)
Volitionrx (VNRX) Revenue Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | 6.08% |
| 10 | Volitionrx | 90,088.41 | -1.03 Mn | - | 203.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 203.93% |
| Sep 30, 2025 | 54.47% |
| Jun 30, 2025 | -12.44% |
| Mar 31, 2025 | 46.14% |
| Dec 31, 2024 | 77.62% |
| Sep 30, 2024 | 218.44% |
| Jun 30, 2024 | 29.31% |
| Mar 31, 2024 | 16.71% |
| Dec 31, 2023 | 166.68% |
| Sep 30, 2023 | 540.11% |
| Jun 30, 2023 | 444.15% |
| Mar 31, 2023 | 26.48% |
| Dec 31, 2022 | -806.98% |
| Sep 30, 2022 | -21.82% |
| Jun 30, 2022 | 60.41% |
| Mar 31, 2022 | 347.36% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 4,331.83% |
| Jun 30, 2021 | 377.13% |
| Mar 31, 2021 | 4,593.01% |